Sigma-Aldrich Investor Relations Sigma-Aldrich Investor Home Home Sigma-Aldrich home page



Investor Relations

Events & Presentations

Oct 22, 2009 at 10:00 AM CT
Q3 2009 Sigma-Aldrich Corporation Earnings Conference Call
Listen to Webcast Listen to Webcast
PDF View Presentation  494.6 KB   Add to Briefcase

View all events & presentations »

Corporate Profile

Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Sigma-Aldrich operates in 37 countries and has over 8,000 employees providing excellent service worldwide.

Recent Releases

Nov 3, 2009
Sigma-Aldrich Signs License Agreement With Polyplus-transfection to Offer Novel ZNA Oligonucleotides

Oct 29, 2009
Sigma-Aldrich® Teams With 3M to Provide TIPS Pentacene Organic Electronics Semiconductor for Growing Printed Electronics Industry

Oct 22, 2009
Sigma-Aldrich (Nasdaq: SIAL) Reports 9.4% Increase in Q3 2009 Diluted EPS; Sales Performance Improved in Q3 2009 Over Earlier 2009 Quarters. Full Year 2009 Diluted EPS Expected to Exceed $2.70.

View all releases »


 

© 2009 Sigma-Aldrich Co. Reproduction forbidden without permission.
Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc. Best viewed in IE5 or higher